Clinical utility of monitoring sialyl Lewis(X) (CD15S) antigen on peripheral lymphocytes for the diagnosis and treatment of rejection after renal transplantation.
BACKGROUND
In organ transplantation, the grafts must be carefully monitored, but it is often difficult to make a quick and accurate diagnosis of unusual changes. Extensive research has failed to identify a useful marker for rejection. We investigated the clinical utility of sialyl Lewis(X) (CD15s) monitoring in 17 renal transplant patients with acute rejection.


METHODS
The expression of CD15s on peripheral lymphocytes was examined using flow cytometry in renal transplant recipients with rejection (n=17), without rejection (n=23), recipients infected with cytomegalovirus (n=7), recipients with other diseases (n=7), and healthy volunteers (n=18). CD15s expression was compared with histological findings, and was also examined before and after steroid pulse therapy to investigate the effects of steroids on CD15s antigen expression on the surface of the peripheral lymphocytes.


RESULTS
CD15s was strongly expressed in all patients with rejection, but was not expressed in any of the patients without rejection or in any healthy volunteers. Histologically, cell infiltration into the rejected graft was moderate or severe in all patients with strong expression of CD15s. In contrast, no or only mild infiltration was observed in patients with weak expression of CD15s. In addition, 14 of 17 patients (14/17, 82%) with strong CD15s expression improved upon administration of steroid pulse therapy, although there was no benefit from steroids in any of the patients with weak expression of CD15s.


CONCLUSIONS
The CD15s antigen is expressed strongly on the peripheral lymphocytes at the time of rejection. It is interesting that the efficacy of steroid therapy in the patients with elevated creatinine could be predicted by CD15s expression on the peripheral lymphocytes before graft biopsy. There have been only few reports showing the relationship between CD markers and the efficacy of the treatment in patients with elevated creatinine. We report that the detection of CD15s on the peripheral lymphocytes by flow cytometry was an easy, helpful, and noninvasive means for the diagnosis and treatment of patients with elevated creatinine after renal transplantation.
Ishida
H
H
Department of Surgery III, Tokyo Women's Medical University, Tokyo, Japan.
Koyama
I
I
Sawada
T
T
Murakami
T
T
Utsumi
K
K
Sannomiya
A
A
Tsuji
K
K
Tojimbara
T
T
Nakajima
I
I
Tanabe
K
K
Fuchinoue
S
S
Yamaguchi
Y
Y
Toma
H
H
Agishi
T
T
D000328:Adult; D000911:Antibodies, Monoclonal; D005260:Female; D005434:Flow Cytometry; D006084:Graft Rejection / Q000175:diagnosis* / Q000188:drug therapy*; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009844:Oligosaccharides / Q000032:analysis*; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012016:Reference Values; D019233:Retreatment; D000080506:Sialyl Lewis X Antigen
D000911:Antibodies, Monoclonal; D006146:Guanidines; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D009844:Oligosaccharides; D000080506:Sialyl Lewis X Antigen; D011239:Prednisolone; C037258:gusperimus